Vigil Neuroscience Stock Market Value

VIGL Stock  USD 3.60  0.10  2.70%   
Vigil Neuroscience's market value is the price at which a share of Vigil Neuroscience trades on a public exchange. It measures the collective expectations of Vigil Neuroscience investors about its performance. Vigil Neuroscience is selling for 3.60 as of the 13th of November 2024. This is a 2.7 percent decrease since the beginning of the trading day. The stock's lowest day price was 3.54.
With this module, you can estimate the performance of a buy and hold strategy of Vigil Neuroscience and determine expected loss or profit from investing in Vigil Neuroscience over a given investment horizon. Check out Vigil Neuroscience Correlation, Vigil Neuroscience Volatility and Vigil Neuroscience Alpha and Beta module to complement your research on Vigil Neuroscience.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.
Symbol

Vigil Neuroscience Price To Book Ratio

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.11)
Return On Assets
(0.40)
Return On Equity
(0.70)
The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vigil Neuroscience 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vigil Neuroscience's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vigil Neuroscience.
0.00
09/14/2024
No Change 0.00  0.0 
In 2 months and 2 days
11/13/2024
0.00
If you would invest  0.00  in Vigil Neuroscience on September 14, 2024 and sell it all today you would earn a total of 0.00 from holding Vigil Neuroscience or generate 0.0% return on investment in Vigil Neuroscience over 60 days. Vigil Neuroscience is related to or competes with Cullinan Oncology, Aerovate Therapeutics, Structure Therapeutics, Nuvectis Pharma, Lyra Therapeutics, Gossamer Bio, and Inhibrx. Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for ... More

Vigil Neuroscience Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vigil Neuroscience's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vigil Neuroscience upside and downside potential and time the market with a certain degree of confidence.

Vigil Neuroscience Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Vigil Neuroscience's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vigil Neuroscience's standard deviation. In reality, there are many statistical measures that can use Vigil Neuroscience historical prices to predict the future Vigil Neuroscience's volatility.
Hype
Prediction
LowEstimatedHigh
0.183.547.64
Details
Intrinsic
Valuation
LowRealHigh
3.427.5211.62
Details
Naive
Forecast
LowNextHigh
0.073.387.49
Details
8 Analysts
Consensus
LowTargetHigh
18.0919.8822.07
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Vigil Neuroscience. Your research has to be compared to or analyzed against Vigil Neuroscience's peers to derive any actionable benefits. When done correctly, Vigil Neuroscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Vigil Neuroscience.

Vigil Neuroscience Backtested Returns

As of now, Vigil Stock is slightly risky. Vigil Neuroscience owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0351, which indicates the firm had a 0.0351% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vigil Neuroscience, which you can use to evaluate the volatility of the company. Please validate Vigil Neuroscience's Coefficient Of Variation of 1271.75, semi deviation of 2.96, and Risk Adjusted Performance of 0.0686 to confirm if the risk estimate we provide is consistent with the expected return of 0.12%. Vigil Neuroscience has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 1.22, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vigil Neuroscience will likely underperform. Vigil Neuroscience right now has a risk of 3.43%. Please validate Vigil Neuroscience downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Vigil Neuroscience will be following its existing price patterns.

Auto-correlation

    
  -0.16  

Insignificant reverse predictability

Vigil Neuroscience has insignificant reverse predictability. Overlapping area represents the amount of predictability between Vigil Neuroscience time series from 14th of September 2024 to 14th of October 2024 and 14th of October 2024 to 13th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vigil Neuroscience price movement. The serial correlation of -0.16 indicates that over 16.0% of current Vigil Neuroscience price fluctuation can be explain by its past prices.
Correlation Coefficient-0.16
Spearman Rank Test-0.03
Residual Average0.0
Price Variance0.02

Vigil Neuroscience lagged returns against current returns

Autocorrelation, which is Vigil Neuroscience stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vigil Neuroscience's stock expected returns. We can calculate the autocorrelation of Vigil Neuroscience returns to help us make a trade decision. For example, suppose you find that Vigil Neuroscience has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Vigil Neuroscience regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vigil Neuroscience stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vigil Neuroscience stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vigil Neuroscience stock over time.
   Current vs Lagged Prices   
       Timeline  

Vigil Neuroscience Lagged Returns

When evaluating Vigil Neuroscience's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vigil Neuroscience stock have on its future price. Vigil Neuroscience autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vigil Neuroscience autocorrelation shows the relationship between Vigil Neuroscience stock current value and its past values and can show if there is a momentum factor associated with investing in Vigil Neuroscience.
   Regressed Prices   
       Timeline  

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Vigil Neuroscience is a strong investment it is important to analyze Vigil Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vigil Neuroscience's future performance. For an informed investment choice regarding Vigil Stock, refer to the following important reports:
Check out Vigil Neuroscience Correlation, Vigil Neuroscience Volatility and Vigil Neuroscience Alpha and Beta module to complement your research on Vigil Neuroscience.
For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Vigil Neuroscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Vigil Neuroscience technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vigil Neuroscience trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...